首页 | 本学科首页   官方微博 | 高级检索  
     

小剂量尿激酶治疗频发短暂性脑缺血发作临床研究
引用本文:刘树国,鲍晓玲,孙志宝. 小剂量尿激酶治疗频发短暂性脑缺血发作临床研究[J]. 泰山医学院学报, 2006, 27(4): 328-329
作者姓名:刘树国  鲍晓玲  孙志宝
作者单位:1. 滨州职业学院中专部,山东,滨州,256609
2. 滨州市人民医院,山东,滨州,256610
摘    要:目的 研究小剂量尿激酶对频发的短暂性脑缺血发作(TIA)的疗效。方法 将64例频发的TIA患者随机分为治疗组和对照组。治疗组在对照组治疗的基础上加用小剂置尿激酶静脉点滴,连续5.7d。结果 治疗组治疗后24h内及72h内TIA发作控制率分别是71.9%和93.8%,均高于对照组18.8%和50%(P〈0.01);且治疗组血浆粘度和纤维蛋白原较对照组明显降低(IP〈0.01)。结论 小剂量尿激酶治疗频发TIA疗效显著、安全、见效快,且能有效防止脑梗死的发生。

关 键 词:尿激酶  治疗  短暂性脑缺血发作
文章编号:1004-7115(2006)04-0328-02
收稿时间:2006-05-10
修稿时间:2006-05-10

A clinical study of small-dose urokinase in the treatment of frequent transient ischemic attack
LIU Shuguo ,BAO Xiaoling. A clinical study of small-dose urokinase in the treatment of frequent transient ischemic attack[J]. Journal of Taishan Medical College, 2006, 27(4): 328-329
Authors:LIU Shuguo   BAO Xiaoling
Affiliation:I. Binzhou Vocational College, Shandong 256609. Sun Zhibao ;2. Binzhou People Hospital, Shandong 256610 China
Abstract:Objective:To study the clinical effect of small-dose urokinase in the treatment of frequent transient ischemic attack(TIA).Methods:Sixty-four patients with TIA were randomly divided into study group and control group.The study group added small-dose urokinase to ivdrip for 5-7 days in the base of the treatment of the control group.Results:The control rates to attack of the study group were respectively 71.9% and 93.8% within twenty-four hours and seventy-two hours after treatment,they were higher than 18.8% and 50% of the control group(P<0.01);and the fibrinogen and serous mucosity of the study group were significantly lower than the control group(P<0.01).Conclusion:Small-dose urokinase is effective and safe in the treatment of frequent TIA,and it can effectively prevent cerebtral infarction.
Keywords:Urokinase   treatment    Transient ischemic attack
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号